| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |